1. Effect of Dietary Mannan Oligosaccharide from Bio-Mos or SAF-Mannan on Live Performance of Broiler Chickens
- Author
-
Benites, V., Gilharry, R., Gernat, A. G., and Murillo, J. G.
- Abstract
A 42-d broiler pen trial was conducted to evaluate the effects of dietary mannan oligosaccharide (MOS) from either of 2 commercial products, Bio-Mos (Alltech Inc., Nicholasville, KY) or SAF-Mannan (S. I. LeSaffre, Cedex, France) each at 2 levels of inclusion on live performance. The MOS, derived from the outer portion of yeast cell walls, is reported to have several beneficial modes of action including 1) pathogen adsorption (agglutination); 2) improved intestinal integrity (e.g., villi height); and 3) immune modulation. Diets were fed in 3 phases, and treatments included a control, 2 Bio-Mos treatments (1.0 kg/ton in starter and 0 or 0.5 kg/ton in grower and finisher feeds), and 2 SAF-Mannan treatments (0.5 kg/ton in starter and 0 or 0.5 kg/ton in grower and finisher feeds), according to the manufacturers’ recommendations. Birds fed Bio-Mos at 1.0/0.5/0.5 (starter/grower/finisher) kg/ton diets had significantly greater BW at 42 d than birds fed control or SAF-Mannan-supplemented diets, whereas results for the Bio-Mos 1.0/0/0 kg/ton diets were intermediate. Supplementation of diets with Bio-Mos at 1.0/0.5/0.5 kg/ton may improve broiler BW at market ages compared with the unsupplemented diets. Feed consumption was lower from 0 to 21 d in the SAF-Mannan treatments compared with other treatments. No significant differences were found for feed conversion or mortality for any of the treatments. Overall, Bio-Mos had a greater effect on bird BW compared with the other variables measured.
- Published
- 2008
- Full Text
- View/download PDF